Oral calcium channel blocker formulations for hypertension management, supplied by pharmaceutical manufacturers to hospitals, clinics, and pharmacies. Procurement professionals in healthcare facilities acquire these for cardiovascular treatment protocols, distributed through B2B medical supply chains for patient dosing regimens.